{"id":260732,"date":"2018-09-04T10:00:03","date_gmt":"2018-09-04T10:00:03","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=260732"},"modified":"2018-09-04T10:00:03","modified_gmt":"2018-09-04T10:00:03","slug":"glycobiology-market-2018-global-trend-segmentation-and-opportunities-forecast-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/glycobiology-market-2018-global-trend-segmentation-and-opportunities-forecast-to-2023_260732.html","title":{"rendered":"Glycobiology Market 2018 Global Trend, Segmentation And Opportunities Forecast To 2023"},"content":{"rendered":"
\n
“Glycobiology”<\/div>\n<\/div>\n
Glycobiology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023<\/div>\n

Glycobiology <\/strong>Industry<\/strong><\/a><\/p>\n

Description<\/strong><\/p>\n

Wiseguyreports.Com Adds “Glycobiology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” <\/strong>To Its Research Database<\/p>\n

The importance of carbohydrates in biological processes has long been underappreciated. Nevertheless, with new tools for synthesizing, modifying and 
studying oligosaccharides and glycoconjugates, the understanding of th ese biomolecules is rapidly improving. This knowledge is also yielding promising candidates for carbohydrate-based diagnostics, drugs and vaccines.<\/p>\n

Importantly, the study of such molecules is technically challenging as no sequencing tool, such as that used in proteomics or genomics, is available. However, following on from genomics and proteomics, there is increasing recognition of the importance of carbohydrate-based molecules in basic cellular processes. The central role of saccharides in cellular interactions means that novel oligosaccharides are of value in R&D programs addressing a wide range of therapeutic areas, including inflammation, immunity, oncology, neurodegenerative disease, infection and more.<\/p>\n

Because of their essential function in many cellular processes, carbohydrates are also important biomarkers in diagnostic assay development.<\/p>\n

This report will highlight the main segments of the glycobiology industry and its major market participants, including current and future market trends. Drivers and challenges in each segment of this industry will be discussed in detail, with a forecast from 2016 through 2021.<\/p>\n

Request for Sample Report @ https:\/\/www.wiseguyreports.com\/sample-request\/3375324-glycobiology-global-markets-for-diagnostics-and-therapeutics<\/a> <\/strong><\/p>\n

SCOPE AND FORMAT<\/strong><\/p>\n

This report presents current and important business tools to evaluate new commercial opportunities in glycobiology diagnostics, therapeutics and research tools market. The geographic scope of this study covers companies in the U.S. and worldwide. This market is complex and consists of number of different segments, each affected differently by scientific and technological development. The report identifies the main positive and negative factors in each segment and forecasts further trends, products and assay developments.Report Scope:<\/p>\n

This report presents current and important business tools to evaluate new commercial opportunities in glycobiology diagnostics, therapeutics and research tools market. The geographic scope of this study covers companies in the U.S. and worldwide. This market is complex and consists of number of different segments, each affected differently by scientific and technological development. The report identifies the main positive and negative factors in each segment and forecasts further trends, products and assay developments.<\/p>\n

Report Includes:<\/strong><\/p>\n

– An overview of the global markets for glycobiology diagnostics and therapeutics. 
– Analyses of market trends, with data from 2015, 2016, and projections of CAGRs through 2021. 
– Analyses of current trends, products, evolving technologies and new glycobiology related platforms in different clinical areas including oncology, immunology, cardiovascular, infectious diseases and neurodegeneration. 
– A look at new tools for synthesizing, modifying and studying oligosaccharides and glycoconjugates. 
– Evaluation of promising candidates for carbohydrate-based diagnostics, drugs and vaccines. 
– Insight into how glycobiology offers enormous untapped potential in the discovery of new therapeutics derived from saccharides or other molecules which target the biosynthesis and function of saccharides. 
– Profiles of major players in the industry.<\/p>\n

Leave a Query @ https:\/\/www.wiseguyreports.com\/enquiry\/3375324-glycobiology-global-markets-for-diagnostics-and-therapeutics<\/a> <\/strong><\/p>\n

 <\/p>\n

Table of Contents <\/strong><\/p>\n

Chapter 1 INTRODUCTION <\/strong>
STUDY GOALS AND OBJECTIVES 
REASONS FOR DOING THIS STUDY 
SCOPE AND FORMAT 
METHODOLOGY AND INFORMATION SOURCES 
INTENDED AUDIENCE 
ANALYST’S CREDENTIALS 
RELATED BCC RESEARCH REPORTS 
BCC RESEARCH WEBSITE 
DISCLAIMER 
Chapter 2 SUMMARY <\/strong>
Chapter 3 INTRODUCTION TO GLYCOBIOLOGY MARKET <\/strong>
OVERVIEW 
GLYCOBIOLOGY DEFINITION 
SIGNIFICANCE OF GLYCAN 
FUNCTION OF GLYCANS AND THEIR BIOLOGICAL SIGNIFICANCE 
RESEARCH TOOLS FOR GLYCOBIOLOGY STUDIES 
STRUCTURAL ANALYSIS OF GLYCANS 
GLYCOMICS AS PART OF GLYCOBIOLOGY RESEARCH 
CHEMICAL AND ENZYMATIC SYNTHESIS OF GLYCANS AND GLYCOCONJUGATES 
BIOINFORMATICS AND DATABASE RESOURCES FOR GLYCOBIOLOGY RESEARCH 
Chapter 4 GLYCOBIOLOGY THERAPEUTICS MARKET <\/strong>
OVERVIEW 
SUBCATEGORIES OF GLYCOBIOLOGY THERAPEUTICS 
GLYCANS AS COMPONENTS OF SMALL-MOLECULE DRUGS 
SMALL-MOLECULE INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE 
THERAPEUTIC GLYCOPROTEINS 
GLYCAN THERAPEUTIC APPROACHES TO METABOLIC DISEASES 
THERAPEUTIC APPLICATIONS OF GLYCOSAMINOGLYCANS 
CARBOHYDRATE-BASED VACCINES AND GLYCANS AS VACCINE COMPONENTS 
BLOCKING GLYCAN RECOGNITION IN DISEASES 
TRANSFUSION AND TRANSPLANTATION REJECTION BY ANTIGLYCAN ANTIBODIES 
GLYCOBIOLOGY THERAPEUTICS IN DEVELOPMENT 
EVALUATION OF GLYCOBIOLOGY THERAPEUTICS MARKET 
OVERVIEW 
MARKET LANDSCAPE 
MARKET TRENDS IN GLYCOBIOLOGY THERAPEUTICS 
PROTEIN AND GLYCAN GLYCOENGINEERING TO ENHANCE EFFICACY AND THERAPEUTIC VALUE 
ENGINEERING GLYCANS AND GLYCAN MIMICS AS THERAPEUTIC AGENTS 
GLYCOBIOLOGY AND DRUG DELIVERY 
OLIGOSACCHARIDE LIBRARIES FOR DRUG DISCOVERY RESEARCH 
GLYCONUTRIENTS AS THERAPEUTICS 
Chapter 5 GLYCOBIOLOGY DIAGNOSTICS MARKET <\/strong>
OVERVIEW 
GLYCOBIOMARKERS AND AUTOIMMUNITY 
GLYCOBIOMARKERS IN INFLAMMATORY BOWEL DISEASE 
AUTOANTIBODIES AGAINST NEURONAL GLYCANS IN CERTAIN NEUROPATHIES 
AUTOANTIBODIES AGAINST TN ANTIGEN IN TN-POLYAGGLUTININ SYNDROME 
GLYCOBIOLOGY MARKERS IN CARDIOVASCULAR DISEASES 
ROLE OF GLYCANS IN THE HISTOPATHOLOGY OF ALZHEIMER’S DISEASE 
GLYCOBIOMARKERS AND ASTHMA 
GLYCOBIOMARKERS IN INFECTIOUS DISEASE TESTING 
MARKET POTENTIAL FOR GLYCOBIOLOGY-BASED BIOMARKERS AND DIAGNOSTIC TESTS 
GLYCOBIOLOGY-BASED CANCER BIOMARKERS AND DIAGNOSTIC DEVELOPMENT 
CURRENT GLYCOBIOLOGY-BASED DIAGNOSTICS ON THE MARKET 
GLUCOSE MONITORING FOR DIABETES 
GLYCOHEMOGLOBIN (HBA1C, A1C) 
CARBOHYDRATE INTOLERANCE TEST 
CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT) 
COMPANIES WITH GLYCOBIOLOGY DIAGNOSTIC PLATFORMS AND PRODUCTS IN DEVELOPMENT 
GENOS GLYKO 
GLYCODIAG 
GLYCOMARK 
GLUCOSENSE DIAGNOSTICS 
GLYCOSENSORS AND DIAGNOSTICS LLC 
GLYCOTECHNICA LTD. 
GLYCOTEST DIAGNOSTICS 
SIGMA DIAGNOSTICS 
MARKET FOR GLYCOBIOLOGY-BASED DIAGNOSTICS 
Chapter 6 MARKET FOR TOOLS AND REAGENTS USED IN GLYCOBIOLOGY RESEARCH AND DEVELOPMENT <\/strong>
OVERVIEW 
ANALYTICAL AND CHROMATOGRAPHY TECHNIQUES 
GLYCAN ARRAYS 
LECTIN ARRAYS 
GLYCOBIOLOGY KITS 
REAGENTS FOR GLYCOBIOLOGY RESEARCH 
CARBOHYDRATES: MONOSACCHARIDES, OLIGOSACCHARIDES AND OTHER REAGENTS 
MARKET FOR TOOLS AND REAGENTS FOR GLYCOBIOLOGY R&D 
Chapter 7 PATENT ANALYSIS OF GLYCOBIOLOGY MARKET <\/strong>
OVERVIEW 
Chapter 8 MARKET SUMMARY <\/strong>
Chapter 9 OVERVIEW OF SELECT COMPANIES IN THE GLYCOBIOLOGY MARKET <\/strong>
BIOMARIN PHARMACEUTICAL INC. 
GLYCOMIMETICS 
GLYCAN BIOSCIENCES LLC 
GLYCOSENSORS AND DIAGNOSTICS LLC 
GLYCOTEST INC. 
Chapter 10 DIRECTORY OF COMPANIES REFERRED TO IN THE REPORT <\/strong>
DIRECTORY OF COMPANIES<\/p>\n

List Of Tables <\/strong>
Summary Table : GLOBAL MARKET FOR GLYCOBIOLOGY, BY SEGMENT, THROUGH 2021 
Table 1 : CLASSIFICATION OF CARBOHYDRATES 
Table 2 : EXAMPLES OF GLYCOSYLATION DEFICIENCY AND THEIR PATHOLOGICAL EFFECT 
Table 3 : EXPERIMENTAL APPROACHES TO STUDYING GLYCANS 
Table 4 : EXAMPLES OF INHIBITORS\/MODULATORS USED IN GLYCOBIOLOGY RESEARCH 
Table 5 : SEPARATION AND IDENTIFICATION TECHNIQUES USED FOR GLYCAN ANALYSIS 
Table 6 : BIOINFORMATICS AND DATABASE RESOURCES FOR GLYCOBIOLOGY RESEARCH 
Table 7 : GLOBAL MARKET FOR SYSTEMIC ANTIBIOTICS, THROUGH 2020 
Table 8 : GLOBAL SALES OF RELENZA AND TAMIFLU, 2014 AND 2015 
Table 9 : GLOBAL SALES OF ARANESP, 2014 AND 2015 
Table 10 : GLOBAL SALES OF ZAVESCA, 2014 AND 2015 <\/p>\n

Buy Now @ https:\/\/www.wiseguyreports.com\/checkout?currency=one_user-USD&report_id=3375324<\/a> <\/strong><\/p>\n

Continued…                        <\/strong><\/p>\n

 <\/strong><\/p>\n

Contact Us: <\/strong>Sales@Wiseguyreports.Com<\/strong><\/a> Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)<\/strong><\/p>\n

 <\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.wiseguyreports.com\/sample-request\/3375324-glycobiology-global-markets-for-diagnostics-and-therapeutics<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Glycobiology” Glycobiology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023 Glycobiology Industry Description Wiseguyreports.Com Adds “Glycobiology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database The importance … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-260732","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/260732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=260732"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/260732\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=260732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=260732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=260732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}